Performance of Mergers and Acquisitions in the Pharmaceutical Industry: A Comparative Perspective

Multinational Business Review

Volumn 15, Issue 2, 2007, Pages 41-62

  Demirbag, Mehmet ^a   ng, Chang Keong ^a   Tatoglu, Ekrem ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

Acquisitions; Mergers; Performance; Pharmaceutical industry; Profit margin

Indexed keywords

EID: 84993030076     PISSN: 1525383X     EISSN: 20541686     Source Type: Journal    
DOI: 10.1108/1525383X200700007     Document Type: Review

References (41)

1. Ahuja, G., and R. Katila. 2001. Technological acquisitions and the innovation performance of acquiring firms: A longitudinal study. Strategic Management Journal 22: 197-220.
2. Andrade, G., M. Mitchell, and E. Stafford. 2001. New evidence and perspectives on mergers. Journal of Economic Perspectives 15(2): 103-120.
3. Andrade, G., and E. Stafford. 2004. Investigating the economic role of mergers. Journal of Corporate Finance 10: 1-36.
4. Barkema, H. G., and F. Vermeulen. 1998. International expansion through start-up or acquisition: A learning perspective. Academy of Management Journal 41(1): 7-26.
5. Berggren, C. 2003. Mergers, MNEs and innovation-the need for new research approaches. Scandinavian Journal of Management 19: 173-191.
6. Brouthers, K. D., and L. E. Brouthers. 2000. Acquisition or greenfield startup? Institutional, cultural and transaction cost influences. Strategic Management Journal 21: 89-97.
7. Buckley, P. J., and P. N. Ghauri. 2002. International Mergers and Acquisitions: A Reader. Stamford, CT: Thomson.
8. Capron, L. 1999. The long-term performance of horizontal acquisitions. Strategic Management Journal 20: 987-1018.
9. Chatterjee, S. 1986. Types of synergy and economic value: The impact of acquisitions on merging and rival firms. Strategic Management Journal 7: 119-139.
10. Danzon, P. M., A. Epstein, and S. Nicholson. 2004. Mergers and acquisitions in the pharmaceutical and biotech industries. NBER Working Paper No. W10536 (June). http://ssrn.com/abstract=556523 (accessed 28-04-2005).
11. Dickerson, A. P., H. D. Gibson, and E. Tsakalotos. 1997. The impact of acquisitions on company performance: Evidence from a large panel of UK firms. Oxford Economic Papers 49: 344-361.
12. The Economist. 1999. Faites vos jeux. December 4: 63.
13. Gaughan, P. A. 2001. Mergers and Acquisitions: An Overview. Fairleigh Dickinson University. http://www.abdn.ac.uk/~acc025/web_pgs/public/courses/ifm/other/GAUGHAN.pdf (accessed 27-04-2005).
14. Ghosh, A. 2001. Does operating performance improve following corporate acquisitions? Journal of Corporate Finance 7: 151-178.
15. Healy, P., K. Palepu, and R. Ruback. 1992. Does corporate performance improve after mergers? Journal of Financial Economics 31: 135-175.
16. Hennart, J. F, and S. Reddy. 1997. The choice between mergers/acquisitions and joint ventures: The case of Japanese investors in the United States. Strategic Management Journal 18: 1-12.
17. Henry, D. 2002. Mergers: Why most big deals don't pay off. Business Week October 14: 60-70.
18. Heracleous, L., and J. Murray. 2001. The urge to merge in the pharmaceutical industry. European Management Journal 19(4): 430-437.
19. Higgins, M. J., and D. Rodriguez. 2004. The outsourcing of R&D through acquisition in the pharmaceutical industry. Working Paper Series (December). http://ssrn.com/abstract=487403 (accessed 15-07-2005).
20. Hitt, M. A., R. E. Hoskisson, R. D. Ireland, and J. S. Harrison. 1991. Effects of acquisitions on R&D inputs and outputs. Academy of Management Journal 34(3): 693-706.
21. Hitt, M. A., R. E. Hoskisson, and R. D. Ireland. 1990. Mergers and acquisitions and managerial commitment to innovation in M-form firms. Strategic Management Journal 11: 29-47.
22. Huck, S., and K. A. Konrad. 2004. Merger profitability and trade policy. Scandinavian Journal of Economics 106(1): 107-122.
23. James, A. D. 2002. The strategic management of mergers and acquisitions in the pharmaceutical industry: Developing a resource-based perspective. Technology Analysis & Strategic Management 14(3): 299-313.
24. Javalgi, R. G., and R. F. Wright. 2003. An international market entry model for pharmaceutical companies: A conceptual framework for strategic decisions. International Journal of Medical Marketing 3(4): 274-286.
25. King, D. R., D. R. Dalton, C. M. Daily, and J. G. Covin. 2004. Meta-analysis of post-acquisition performance: Indication of unidentified moderators. Strategic Management Journal 25: 187-200.
26. Koenig, M. E. D., and E. M. Mezick. 2003. Impact of mergers and acquisitions on research productivity within the pharmaceutical industry. Scientometric 59(1): 157-169.
27. Kogut, B., and H. Singh. 1988. The effect of national culture on the choice of entry mode. Journal of International Business Studies 19(3): 411-432.
28. Li, A. W. P. 1998. Mega-mergers in the pharmaceutical industry. Pharmacoeconomics 4(4): 349-355.
29. Lubatkin, M. 1983. Mergers and the performance of the acquiring firm. Academy of Management Review 8(2): 218-225.
30. Morgan, E. J. 2001. Innovation and merger decision in the pharmaceutical industry. Review of Industrial Organization 19: 181-197.
31. Neild, C., and D. Alcraft. 2001. Pharmaceutical and biotechnology mergers and acquisitions: The glass ceiling. International Journal of Medical Marketing 2(1): 88-91.
32. Price Water house Coopers. 2004. Pharmaceutical Sector Insights 2003. http://www.pwc.com/gx/eng/about/svcs/cf/pwc_PharmaInsights04. pdf (accessed 2-05-2005).
33. Schweizer, L. 2002. The key drivers and success factors for M&A strategies in the biotechnological and pharmaceutical industry. Pharmaceutical Policy and Law 5: 41-62.
34. Sellers, L. J. 2004. Pharm Exec 50. Pharmaceutical Executive. http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=95192 (accessed 2-05-2005).
35. Seth, A. 1990. Sources of value creation in acquisitions: an empirical investigation. Strategic Management Journal 11: 431-446.
36. Shimizu, K., M. A. Hitt, D. Vaidyanath, and V. Pisano. 2004. Theoretical foundations of cross-border mergers and acquisitions: A review of current research and recommendations for the future. Journal of International Management 10(3): 307-353.
37. Singh, H., and C. A. Montgomery. 1987. Corporate acquisition strategies and economic performance. Strategic Management Journal 8: 377-386.
38. Sudarsanam, S. 2003. Creating Value from Mergers and Acquisitions. Pearson Education Limited.
39. Tkachenko, L., and S. Fiagbedzi. 2002. Profit and value creation in pharmaceutical industry cross-border mergers. Goteborg, Graduate Business School. http://www.handels.gu.se/epc/archive/00001348/ (accessed 13-08-2005).
40. The Association of the British Pharmaceutical Industry. 2004. Facts & Statistics from the Pharmaceutical Industry. http://www.abpi.org.uk /sta-tistics/section.asp?sect=1#4 (accessed 28-04-2005).
41. Trombetta, W. 2003. Industry audit and fab four companies of the year. Pharmaceutical Executive. http://www.pharmexec.com/pharmexec /article/articleDetail.jsp?id=68647 (accessed 2-05-2005).